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Abstract 
Hospital wastewaters are a main source of pharmaceutical active compounds, 
which are usually highly recalcitrant and can accumulate in surface and 
groundwater bodies. Fungal treatments can remove these contaminants prior to 
discharge, but real wastewater poses a problem to fungal survival due to 
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bacterial competition. This study successfully treated real non-spiked, non-
sterile wastewater in a continuous fungal fluidized bed bioreactor coupled to a 
coagulation-flocculation pretreatment for 56 days. A control bioreactor without 
the fungus was also operated and the results were compared. A denaturing 
gradient gel electrophoresis (DGGE) and sequencing approach was used to 
study the microbial community arisen in both reactors and as a result some 
bacterial degraders are proposed. The fungal operation successfully removed 
analgesics and anti-inflammatories, and even the most recalcitrant 
pharmaceutical families such as antibiotics and psychiatric drugs. 
Keywords: fungal bioreactor, pharmaceutical active compounds, continuous 
treatment, non-sterile, hospital wastewater, pretreatment 
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1. Introduction 
 
Pharmaceutical active compounds (PhACs) have been found in water bodies at 
significant concentrations (Gros et al., 2012). The primary source of these 
contaminants in the environment is known to be through wastewater treatment 
plant (WWTP) effluents, not designed to remove these emerging pollutants 
(Deblonde and Hartemann, 2013). PhACs are found at especially high 
concentrations (up to µg·L-1 and mg·L-1) in hospital wastewater (HWW), which 
is typically discharged untreated into the sewer network. In consequence, the 
on-site treatment of these hospital effluents prior to discharge  has arisen as a 
promising possibility (Verlicchi et al., 2012). These recalcitrant compounds 
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would be total or partially degraded and transformed into more degradable 
compounds for further downstream treatment.  
White-rot fungi (WRF) have demonstrated the capability to degrade several 
PhACs and consequently, a fungal approach to treat on-site hospital effluents 
emerges as an attractive perspective. First studies on fungal treatment 
performance concerning pharmaceutical removal were carried out in sterile 
conditions and with single-spiked pollutants ( Marco-Urrea et al., 2009, 2010; 
Jelic et al., 2012). Studies in non-sterile more complex matrices are scarcer but 
have demonstrated the ability of fungi to transform and/or remove PhACs from 
non-sterile HWW  (Cruz-Morató et al., 2013). One of the drawbacks of the 
technology in non-sterile conditions is the difficulty in maintaining the fungal 
activity for a long period of time since bacteria exert competitive pressure in 
fungal survival. The implementation of a coagulation-floculation step before the 
fungal treatment of spiked HWW reduced the microbial load of the influent thus 
allowing the maintenance of fungal activity for 28 days (Mir-Tutusaus et al., 
2016). Furthermore, a partial biomass renovation, previously described by 
Blánquez et al. (2006), could extend the treatment by overcoming the biomass 
aging process. This approach has been implemented and is discussed in the 
present manuscript. To approach a real application, a non-spiked matrix is 
preferred.  
Additionally, despite some studies have investigated the bacterial and fungal 
communities in fungal bioreactors treating wastewater (Badia-Fabregat et al., 
2015), it still remains unclear which microorganisms are responsible for the 
PhACs elimination. The assessment of microbial assemblage would enhance 
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the knowledge about this type of systems and help in the design of future 
treatments. 
This study provides the validation of previous work in spiked HWW (Mir-
Tutusaus et al., 2016), while approaching real application. The main focus of 
the manuscript has been the discussion of PhACs removal and its relation to 
microbial community evolution. Moreover, a long operation of this kind of 
reactors in non-sterile HWW has never been achieved before and it would 
signify a promising step in the maturation of fungal technology in wastewater 
treatment. The objectives of the study are thus to test the ability of WRF 
Trametes versicolor to treat real non-sterile HWW after a coagulation-
flocculation pretreatment for a long period of time, to evaluate the bacterial and 
fungal communities arisen during the treatment and to assess the removal 
efficiency for PhACs. 
 
2. Materials and methods 
 
2.1. Reagents, fungus and hospital wastewater 
All the pharmaceutical and the corresponding isotopically labelled standards 
used in the analysis were of high purity grade (>90%) and they were purchased 
from Sigma–Aldrich (Steinheim, Germany), US Pharmacopeia USP (MD, USA), 
Europea Pharmacopoeia EP (Strasbourg, France), Toronto Research 
Chemicals TRC (Ontario, Canada) and CDN isotopes (Quebec, Canada). 
Individual as well as isotopically labelled standard solutions were prepared 
according to Gros et al. (2012).Thiamine hydrochloride was acquired from 
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Merck (Barcelona, Spain), peptone and yeast extract from Scharlau (Barcelona, 
Spain) and glucose, ammonium chloride and other chemicals were purchased 
from Sigma-Aldrich (Barcelona, Spain). All other chemicals used were of 
analytical grade. 
T. versicolor (ATCC#42530) was maintained on 2% malt agar slants at 25°C 
until use. Subcultures were routinely made. A mycelial suspension of T. 
versicolor was obtained as previously described by Blanquez et al (2004). 
The HWW was collected directly from the sewer manifold of Sant Joan de Déu 
Hospital (Barcelona, Spain). Fresh samples were collected in two occasions 
prior to every experiment and stored at 4°C. The characteristics of the 
wastewaters are summarized in Table 1. 
2.2. Medium and pellet formation 
Fungal pellets were obtained as previously described (Mir-Tutusaus et al., 
2016). The defined medium contained per liter: glucose 10 g, macronutrients 
100 mL, micronutrients 10 mL, NH4Cl 2.1 g and thiamine 10 mg (Borràs et al., 
2008). The pH was controlled at 4.5 by adding HCl 1M or NaOH 1M and the 
saturation percentage of dissolved O2 was measured to ensure proper aeration. 
Fluidized conditions in the reactors were maintained by using 1s air pulse every 
4s. The aeration rate was 0.8 L·min-1 and the temperature was maintained at 
25°C. 
2.3. HWW treatment 
Wastewater was pretreated with a coagulation-flocculation process. Coagulant 
HyflocAC50 and flocculant HimolocDR3000 were kindly provided by Derypol, 
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S.A. (Barcelona, Spain). The pretreatment involved 2 min of coagulation at 200 
rpm, 15 min of flocculation at 20 rpm and 30 min of settling. HWW1 and HWW2 
were pretreated with 95 mg·L-1 and 190 mg·L-1of coagulant and 10 mg·L-1 and 
20 mg·L-1 of flocculant, respectively. 
After the pellet growth, the medium was withdrawn and the bioreactor was filled 
with the pretreated HWW. Two bioreactors were run in parallel, one inoculated 
with T. versicolor (RA) and one uninoculated control (RB), both operating 
continuously with a hydraulic residence time (HRT) of 3 days. HWW1 was used 
for the startup and during the first 29 days of operation of both RA (inoculated 
with T. versicolor) and RB (uninoculated control) bioreactors, whereas HWW2 
was used for the following 27 days in both reactors. Nutrients for maintenance, 
glucose and NH4Cl, were added with a molar C/N ratio of 7.5 at T. versicolor 
consumption rate to both reactors (1200 mg glucose·gDCW-1·d-1). A partial 
biomass renovation strategy was carried out in the fungal bioreactor, as 
described by Blánquez et al. (2006), with 1/3 of biomass renovated every 7 
days which produced a cellular retention time (CRT) of 21 d. 
2.4. Analysis of pharmaceuticals 
The analytical procedure performed is based on Gros et al. (2012). Briefly, the 
samples were filtered through 0.45 µm glass fibber filters. Then,  25 mL of 
sample for raw HWW and 50 mL for treated wastewater were pre-concentrated 
by SPE (Solid Phase Extraction) using Oasis HLB (3cc, 60 mg) cartridges 
(Waters Corp. Mildford, MA, USA), which were  previously conditioned with 5 
mL of methanol and 5 mL of HPLC grade water. Elution was done with 6 mL of 
pure methanol. The extracts were evaporated under nitrogen stream and 
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reconstituted with 1 mL of methanol-water (10:90 v/v). 10 µL of internal 
standards mix at 1 ng·µL-1 in methanol were added in the extracts for internal 
standard calibration. Chromatographic separation was carried out with an Ultra-
Performance liquid chromatography (UPLC) system (Waters Corp. Mildford, 
MA, USA), equipped with an Acquity HSS T3 column (50 mm x 2.1 mm i.d. 1.7 
μm particle size) for the compounds analyzed under positive electrospray 
ionization (PI) and an Acquity BEH C18 column (50 mm × 2.1 mm i.d., 1.7μm 
particle size) for the ones analyzed under negative electrospray ionization (NI), 
both from Waters Corporation. The UPLC instrument was coupled to 5500 
QqLit, triple quadrupole–linear ion trap mass spectrometer (5500 QTRAP, 
Applied Biosystems, Foster City, CA, USA) with a Turbo V ion spray source. 
Two multiple reaction monitoring (MRM) transitions per compound were 
recorded by using the Scheduled MRMTM algorithm and the data were acquired 
and processed using Analyst 2.1 software. 
2.5. Microbial Community Analysis 
Liquid samples from each reactor were filtered through 0.22 µm GV Durapore® 
membrane filters (Merck Millipore, USA) and filters were stored at -80ºC. 
Sampled pellets were centrifuged at 14.000 rpm and liquid fraction was 
discarded before cold-storage at -80ºC. Total DNA extraction was conducted 
using the PowerWater® and PowerSoil® DNA Isolation Kits (MoBio 
Laboratories, USA) for filters and pellets, respectively. For bacterial analyses, a 
550 bp DNA fragment in the 16S region of the small subunit ribosomal RNA 
gene was amplified using the primer set 341f/907r (Muyzer et al., 1993) with a 
GC clamp added at the 5’ end of primer 341f. Final concentrations of the PCR 
reactions consisted of 1x PCR buffer, 2 mM of MgCl2, 200 µM of each 
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deoxynucleoside triphosphate, 500 nM of each primer and 2.5 U of Taq DNA 
polymerase (Invitrogen, ThermoFisher Scientific, USA). Amplification protocol 
consisted of: 94ºC for 5 min; 20 cycles of 94ºC for 1 min, 65ºC for 1 min (-
0.5ºC/cycle), 72ºC for 3 min; 15 cycles of 94ºC for 1 min, 55ºC for 1 min, 72ºC 
for 3 min; and a single final extension of 72ºC for 7 min. Fungal DNA was 
amplified using a nested approach over a ~400 bp fragment from the internal 
transcribed spacer (ITS) of fungal ribosomal RNA gene. The primer sets used 
were EF4/ITS4 and ITS1f-GC/ITS2 (Gardes and Bruns, 1993; White et al., 
1990) for the first and second round of amplification, respectively. The GC 
clamp was added at the 5’ side of primer ITS1f and PCR reactions had the 
same final concentrations except for MgCl2 (1.5 mM). PCR program for fungi 
was identical for both amplification rounds and consisted of: 95ºC for 5 min; 35 
cycles of 94ºC for 30 s, 55ºC for 30 s, 72ºC for 30 s; and a single final extension 
72 ºC for 5 min. 
Denaturing gradient gel electrophoresis (DGGE) was performed using the 
Dcode Universal Mutation Detection System (Bio-Rad, Spain). 900 ng of DNA 
from PCR products were loaded onto 6% (w/v) polyacrylamide gels 
(acrylamide/bis solution 37.5:1) containing linear chemical gradients 30-70% 
denaturant for bacteria and 15-55% denaturant for fungi. 100% denaturing 
solution contained 7 M urea and 40% (v/v) deionized formamide. Gels were run 
in 1X Tris acetate-EDTA (TAE) for 16 h at 75 V and 60ºC, stained with 1 µg/mL 
ethidium bromide solution for 25 min, washed with deionized water 25 min and 
photographed with Universal Hood II (Bio-Rad, Spain). DGGE images were 
analysed using InfoQuest™ FP software. Dice’s coefficient and unweighted pair 
group method with arithmetic averages (UPGMA) were employed for the 
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clustering of DGGE gel profiles. Prominent bands from the DGGE were excised, 
re-amplified and then sequenced by Macrogen (South Korea). Obtained 
sequences were trimmed with FinchTV software and checked for chimeras 
using Mothur (Schloss et al., 2009). Each 16S rRNA sequence was assigned to 
its closest neighbor according to the Basic Local Alignment Search Tool 
(BLAST) results (Altschul et al., 1997).   
2.6. Vibrio fischeri bioluminescence inhibition test (Microtox® test) 
Microtox acute toxicity bioassay kit from Azur Environmental (Carlsbad, US) 
was used in toxicity tests. Briefly, the test is based on the diminution of bacterial 
bioluminescence after 5 and 15 min of exposure to dilutions of the samples (pH 
7). Toxicity was expressed as toxicity units (TU).  
2.7. Other analyses 
Glucose concentration was measured per triplicate with a YSI 2700 SELECT 
enzymatic analyzer (Yellow Spring Instruments). Laccase activity was 
measured per triplicate using the method previously described (Mir-Tutusaus et 
al., 2016). The conductivity was determined by a CRISON MicroCM 2100 
conductimeter, and the absorbance at 650nm was monitored by a UNICAM 
8625 UV/VIS spectrometer. Chloride, sulfate, nitrate and phosphate anions 
were quantified by a Dionex ICS-2000 ionic chromatograph. The total 
suspended solids (TSS), dissolved inorganic carbon (DIC) and dissolved 
organic carbon (DOC) were determined according to APHA-AWWA-WEF 
(1995). The N-NH4
+ concentration and chemical oxygen demand (COD) were 
analyzed by using commercial kits LCH303 and LCK114 or LCK314, 
respectively (Hach Lange, Germany). 
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2.8. Statistical analysis 
As recommended by Bolks et al. (2014), a robust Regression on Order 
Statistics (ROS) approach was used for dealing with left-censored data, namely: 
below limit of detection (BLD) and below limit of quantification (BLQ) values. 
When ROS was not possible, values BLD and BLQ were considered to have a 
concentration half of the limit of detection and half of the limit of quantification, 
respectively(EPA, 2000). ROS analysis was performed using the R package 
NADA (Lee, 2013). Other calculations like summary statistics, pharmaceutical 
removals and one-factor analysis of variance (ANOVA) were performed with R: 
A language and environment for statistical computing (R Core Team, 2015). 
Differences were considered as significant at p < 0.05. 
3. Results 
The results of HWWs characterization (Table 1) show that the measured 
physicochemical parameters were in the same range as other HWW. 
Pharmaceuticals concentrations, presented in Table 2 ranged from ng·L-1 to few 
µg·L-1, results also in agreement with previous studies (Badia-Fabregat et al., 
2015; Cruz-Morató et al., 2013). The pretreatment diminished the absorbance 
at 650 nm from 0.215 and 0.265 to values very close to zero and the COD from 
633 and 1012 mg O2·L
-1 to 215 and 300 mg O2·L
-1, respectively. This reduction 
is in accordance with previous experiments (Mir-Tutusaus et al., 2016). 
As stated before, in the case of RA 1/3 of biomass was purged and renovated 
with fresh pellets every 7 days as an approach to maintain a stable and active 
culture in the bioreactor. The control reactor RB was not inoculated. A fungal 
control reactor without biomass renovation was not operated, so the impact of 
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biomass replacement in length of operation will not be included in the RA/RB 
comparison. A complete study on biomass renovation can be found elsewhere 
(Blánquez et al., 2006) in sterile conditions. In addition, present results can be 
compared to those previously described in the treatment of HWW in non-sterile 
conditions without biomass renovation (Mir-Tutusaus et al., 2016). The fungal 
reactor (RA) underwent an incident where pH was sustained below 3 for several 
hours. pH is critical in fungal systems, as supported by Borràs et al. (2008), and 
this low pH period leaded to a substantial loss of pelleted morphology. This 
incident took place during the change of HWW, circumstance that hampered the 
interpretation of results. The reactor recovered pelleted morphology and 
laccase production through weekly biomass renovation but behaved differently 
apropos of PhACs removal. The main conclusions of the treatment could be 
drawn from the first 28 days of operation; however, understanding the second 
period and the recovery from a low pH period could expand the knowledge of 
the system and give insight towards real application, hence all the results are 
presented.  
3.1. Monitoring of bioreactors 
The lack of on-line monitoring variables usually difficults the evaluation of the 
bioreactor performance. In this operation laccase activity and glucose 
concentration were measured during the treatments (Figure 1). Laccase activity 
was not detected in the reactors during the first period of operation (HWW1); 
however, T. versicolor produced the enzyme because when biomass was 
removed from the reactors, rinsed and placed in stirred Erlenmeyers with 
defined medium (ex situ assay), laccase activity could be measured. Ex situ 
assays detected laccase activity in RA but not in RB (data not shown). During 
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the second period of operation (HWW2) laccase profile in RA was irregular with 
peaks of over 45 U·L-1 at Days 30, 45 and 50. Laccase activity in the 
uninoculated reactor remained insignificant throughout the treatment. T. 
versicolor remained active during the whole treatment. However, it could not be 
asserted whether HWW1 interfered with the assay, the production of laccase, or 
some compounds in HWW1 inactivated the laccase. In complex matrices, the 
purification of the laccase is required prior to the measurement of the activity 
(D’Annibale et al., 2006) and it should be taken into accout in future studies. As 
previously discussed (Mir-Tutusaus et al., 2016), laccase production was sign of 
T. versicolor activity, but its absence was not an indication of the fungus 
inactivity. In fact, as argued in the Discussion section, RA showed high removal 
capacity when laccase activity was very low. 
Glucose was added at T. versicolor consumption rate thus glucose 
concentration remained at values close to zero throughout the treatment in the 
fungal reactor. In RB glucose accumulated during the first two weeks of 
operation until it was colonized by HWW-native microorganisms and remained 
insignificant from that point onwards. Total COD is presented in Table 3. RA did 
not significantly increase initial COD except around the day of the pH incident. 
This agreed with the observed loss of pelleted morphology, as free hyphae 
increased the COD load.  Contrarily, RB consistently exhibited COD around 
1200 mg·L-1. The profiles of TSS concentration are presented in Fig. 2. RA 
profile was mostly constant at around 120 mg·L-1, but the control RB did not 
achieve a steady state, exhibiting a much more irregular profile with peaks of 
over 2000 mg·L-1 at the end of the treatment. Neither COD nor TSS levels 
reached the European Union standard of 125 mg·L-1 and 35 mg·L-1, 
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respectively, in either reactor (EEC Council, 1991); but the objective was to 
remove PhACs. The system is, as stated before, an on-site treatment prior to 
discharge to the sewer network. 
3.2. PhACs removal and toxicity assessment 
46 out of the 81 PhACs analyzed were detected during the treatments (Table 
2). In 35 and 34 compounds were detected in raw wastewater HWW1 and 
HWW2, respectively, whereas after the pretreatment only 34 and 32. The two 
pretreated wastewaters used as influent had different PhAC composition. 
Overall, HWW1 had higher concentrations of detected PhACs than HWW2. The 
most common families of PhACs detected were analgesics and anti-
inflammatories, antibiotics and psychiatric drugs, as the hospital has an 
important psychiatric pavilion. Initial concentrations of individual 
pharmaceuticals can be found in Table 2. The analgesics and anti-
inflammatories family contribute the most to the final concentration, especially 
due to the high concentrations of ibuprofen and acetaminophen. Psychiatric 
drugs, led by 2-hydroxycarbamazepine and 10,11-epoxycarbamazepine (both 
known metabolites of carbamazepine), are the second group in concentration. 
Lipid regulators family ranked 3rd followed by antibiotics family.  
Excluding analgesics and anti-inflammatories, which is a family known to be 
easily degraded, the amount of compounds was 17.8 µg·L-1 and decreased to 4 
± 1 µg·L-1 and 9 ± 1 µg·L-1 in reactors RA and RB, respectively, corresponding 
to a removal of 78 ± 7% and 48 ± 4%. In HWW2, when RA was recovering from 
the pH incident, the removal percentages excluding analgesics and anti-
inflammatories were around 30-35% for both reactors. 
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Time-course profile of concentrations of the different families during the 
treatments is presented in Fig. 3. Analgesics and anti-inflammatories were 
present in a high concentration, but were rapidly removed by both the 
inoculated and the uninoculated reactor with removal values of above 80%, as 
both bacteria and fungi are reported to remove these compounds (Langenhoff 
et al., 2013). Both reactors exhibited an increase in removal capacity from day 9 
to day 27, around the time of the change in wastewater, which contained 
approximately half of the concentration of PhACs than HWW1. From that point 
onwards, both RA and RB behaved steadily with removal values of around 
90%.  
Antibiotics initial concentration was around 5000 ng·L-1. T. versicolor was able 
to remove 90% of its initial load but gradually lost removal capacity to values 
around 50%. RB did not significantly remove antibiotics; its concentrations 
remained equal or increased. Since the pH incident, RA did not recover removal 
capacity. RB continued to exhibit higher antibiotics concentration than the inlet 
when treating HWW2.  
The presented psychiatric drugs family excludes carbamazepine (CBZ) and its 
transformation products (TP); carbamazepine case is discussed below because 
it is an especially recalcitrant compound not removed in conventional WWTPs 
and information on the TPs was available (Clara et al., 2004). T. versicolor was 
able to remove around 50% of the initial load of psychiatric drugs, although its 
initial removal was 86%. The uninoculated reactor did not remove this family 
and presented higher concentrations than the inlet during all the treatment.  
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The concentration profile of other pharmaceutical compounds is particularly 
different in the two wastewaters. The first 27 days showed nearly constant 
concentrations of around 900 ng·L-1 in the fungal reactor and around 2500 ng·L-
1 in RB. This translates to removal values of circa 90% for RA and 70% for RB. 
During the second part of the treatment, both reactors behaved similarly with 
removals around 60%. None of the compounds detected had anti-fungal 
activity.  
The case of carbamazepine and its transformation products 10,11-
carabamazepine, 2-hydroxycarbamazepine and acridone is presented in Fig. 4. 
Carbamazepine is mainly metabolized in the liver, generating the analyzed 
transformation products, among other metabolites as well as several 
glucuronide conjugates (Kaiser et al., 2014). Both HWW1 and HWW2 contained 
similar concentrations of CBZ and its TPs, excluding 10,11-expoxyCBZ, with a 
concentration much more higher in HWW2 than in HWW1. The fungal 
bioreactor was able to remove from 50 – 80% of CBZ, around 50% of 10,11-
epoxyCBZ and nearly 100% of 2-hydroxyCBZ, but the concentration of acridone 
increased. While recovering from the pH incident, RA behaved differently: it 
retained the 2-hydroxyCBZ removal capacity and the concentration of acridone 
increased, but it exhibited low removals of CBZ and 10,11-epoxyCBZ. RB was 
not able to remove CBZ from the wastewaters. It showed, nonetheless, good 
removal values of carbamazepine TPs but lost removal capacity from day 27 
onwards. After day 42 RB regained its ability to remove 10,11-epoxyCBZ and 
small amounts of 2-hydroxyCBZ; concentration of acridone also increased. 
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Regarding the toxicity assessment, the fungal reactor maintained the toxicity at 
0 TU during the whole treatment. Contrarily, the control bioreactor raised toxicity 
to 27 TU. 
3.3.  Evolution of bacterial and fungal populations 
The evolution of fungal and bacterial populations was studied by DGGE 
analysis and DNA sequencing. Two DGGE gels (one for bacteria and one for 
fungi) were run with samples collected from the liquid matrix of RA (RA), from 
the pelleted biomass in RA (PRA) and from the liquid matrix of RB (RB). The 
results are presented in figures 5-6 and the DGGE profiles in supplementary 
material (Figure S1). Microbial communities in both reactors changed during the 
treatment and longer operations might be needed to achieve a steady state. 
64 prominent bands from the fungal DGGE were excised and sequenced, 
obtaining 97% coverage of the phylotypes associated with the quantitative 
DGGE band matrix. Representative sequences were submitted to the 
GeneBank database under the accession numbers KX530041 to KX530058. 
While only two phyla (Ascomycota and Basidiomycota) were represented in the 
fungal sequences, these were composed by 7 different genera: Candida, Isaria, 
Phialemoniopsis and Trichoderma from phyla Ascomycota and Asterotremella, 
Trametes and Tremella from phyla Basidiomycota (supplementary material 
table S1).  
At the genus level, Trametes was consolidated all along the operation in pellet 
samples (PRA). When pellets started losing shape, T. versicolor was also found 
in the supernatant samples (RA). Tremella and Asterotremella were dominant in 
RA reactor initially, until Candida was established in mid-late period after the pH 
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incident. Moreover in RB reactor Asterotremella and Trichoderma predominated 
before the change of WW, then a substitution of the former for Phialemoniopsis 
was observed from day 21 onwards. 
In parallel, 74 prominent bands from the bacterial DGGE were excised and 
sequenced. In this case the community coverage also stood in 97%. Sequences 
from each phylotype were submitted to GeneBank under accession numbers 
KX523866 to KX523887. These sequences represented 5 phyla 
(Actinobacteria, Bacteroidetes, Cyanobacteria, Firmicutes and Proteobacteria) 
consisting of 17 different genera.  Proteobacteria was the most widely 
represented phylum with Acetobacter, Burkholderia, Comamonas, 
Magnetospirillum, Pandoraea, Rhizobium and Sternotrophomonas genera. For 
this reason, classes within Proteobacteria were taken into account to evaluate 
the data. Bacteroidetes followed with four affiliated genera, namely, 
Bacteroides, Dyadobacter, Elisabethkingia and Flavobacterium. 
Faecalibacterium, Lactococcus and Paenibacillus genera made up for the 
Firmicutes phylum (supplementary material Table S1). Results revealed a co-
dominance of Betaprotoebacteria and Bacteroidetes in RB during all operation 
with some fluctuations. In RA and PRA the class Betaproteobacteria was 
generally persistent all along the operation. Additionally, Bacteroidetes were 
abundant in early-mid stages of the operation while Alphaproteobacteria class 
took over at mid-late operation.  
4. Discussion 
The consortia established in the reactors were well adapted to lower pH, as 
both reactors were controlled at pH 4.5, and to aerobic conditions, as the 
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reactors were aerated. Differences in bacterial populations between RA and RB 
were due to the presence of pelleted fungal biomass (i.e. in RA, contrarily to 
RB, Firmicutes were present until Day 9 and Proteobacteria α were 
predominant from Day 42 onwards). Differences in removal percentages cannot 
be directly linked to laccase production, as RA showed high removal values 
even when laccase activity was very low or not detected at all. This decoupling 
between laccase activity and PhACs removal can be explained by the diverse 
removal pathways of PhACs, some of which can be removed by mechanisms 
other than the laccase system –notably the cytochrome P450 in the case of 
fungal systems (Blánquez et al., 2004; Jelic et al., 2012; Marco-Urrea et al., 
2010). Therefore, removal capacity will be discussed in terms of microbial 
community shifts. 
Despite the differences, good removals are observed in the analgesics and anti-
inflammatories family in both reactors. Several microorganisms are known 
capable of degrading some compounds of this group. In particular, 
acetaminophen and ibuprofen have been largely studied and can be degraded 
by bacteria as well as fungi (Langenhoff et al., 2013; Nguyen et al., 2014). The 
two compounds account for the high removal of this family in both reactors. RB 
removal did not reach 80-90% until microorganisms fully colonized the reactor, 
around Day 18, when glucose reached near zero values. RA removal increase 
during the first 14 days could only be partially explained by the growth of 
microorganisms other than T. versicolor. A second contribution could be the 
increase in concentration of ketoprofen in RA, hence reducing the overall 
removal. T. versicolor can degrade well over 80% of ketoprofen in the same 
matrix and at the same HRT when the compound is in spiked concentration 
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(Mir-Tutusaus et al., 2016). This fact demonstrated that the concentration 
increase in this non-spiked matrix is probably due to deconjugation of 
glucuronide conjugates of ketoprofen, and that ketoprofen conjugated 
compounds were in fact at higher concentrations. This was in agreement with 
Jelic et al. (2015), which stated that an 80% of the ketoprofen is excreted of the 
human body as a glucuronide-conjugated. In addition, the ability of T. versicolor 
to cleave conjugates of pharmaceutical compounds has been reported before in 
similar fungal systems (Badia-Fabregat et al., 2015; Cruz-Morató et al., 2013). 
The described ketoprofen concentration augment was not mirrored in RB, 
indicating that the microbial consortium did not reverse-transform conjugated 
compounds or that the community also removed such reverse-transformed 
products.  
The case of diclofenac is of interest because it is widely used and not efficiently 
removed in conventional WWTP (Verlicchi et al., 2012). It was present only in 
HWW1 and completely removed during the fungal treatment, in accordance with 
Cruz-Morató et al. (2013). The uninoculated reactor also achieved a >90% 
removal; diclofenac degraders have been found in activated sludge with 
associated removal rates as low as 40% (Bouju et al., 2016). To our knowledge, 
this is the first time diclofenac has been reported to be completely removed by 
biostimulated wastewater-native microorganisms, although with an HRT of 3 
days. This was achieved under non-steady conditions in terms of TSS, although 
diclofenac removal was indeed constant. The responsible candidates could be 
bacteria within the Proteobacteria (Burkholderia, Comamonas or Microvirgula) 
and Bacteroidetes (Elisabethkingia) phyla or fungi as Asterotremella or 
Phialemoniopsis. The genus Elisabethkingia contains species associated with 
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meningitis and to this date none of them have been described (nor studied) as 
degraders. Some species of Burkholderia have been found to degrade several 
pollutants such as chlorinated compounds (Zhang et al., 2013). Comamonas 
representatives have been found to degrade steroids and 4-chlorophenol 
(Linares et al., 2008; Tobajas et al., 2012). Microvirgula is a well-known genus 
of aerobic denitrifiers, which has also been reported to degrade several dyes 
(Han et al., 2012). Regarding the fungal candidates, Phialemoniopsis genus is 
usually related to eye infections and not reported to degrade PhACs. 
Asterotremella proliferation in the fungal pellets, as can be seen in Fig. 5, 
correlated with the decrease in PhACs removal. Microscopic observations were 
not carried out so this fact could not be confirmed. Although the liquid fraction in 
the pellet samples is very low, the Asterotremella percentage is higher than the 
corresponding to the liquid fraction, so it evidences an interaction between 
fungi. In addition, scarcely any references can be found about the yeast and 
none of them regarding its ability to biotransform any compounds. Thus, we 
propose that Asterotremella was not involved in the biotransformation of 
diclofenac.  
Antibiotics are resistant to bacterial biodegradation but not to fungal 
degradation. This trend can be observed in Fig. 3 and Table 2, where no 
removal is appreciated in the uninoculated reactor. Contrarily, the fungal 
reactor, whose main biomass was pelleted fungi, showed very high removals of 
all the antibiotics detected during HWW1. The decrease in removal efficiency of 
RA could be clearly attributed to the loss of predominance of T. versicolor to 
Asterotremella in the fungal pellets, as seen in Fig. 5. The fungal reactor 
behaved equally as RB during HWW2 treatment, with no antibiotics removal. As 
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presence of T. versicolor is demonstrated by DGGE results (Fig. 5) and activity 
of the fungus, by laccase activity results (Fig. 1.), the absence of removal could 
be attributed to inhibition of T. versicolor or its degrading enzymes. Pandoraea 
and Rhizobium were the main bacterial genera present in the liquid matrix and 
pellets during the stated period. Trichoderma was present in the HWW and 
established without apparent difficulties in the non-inoculated bioreactor. 
However, antagonism with Trametes was expected to take place in reactor A to 
the detriment of Trichoderma, as Trametes was the one that prevailed. 
Similarly, Isaria was also abundant in the HWW but was not able to establish, 
not even in the control reactor. Candida was the main fungal genus in the liquid 
matrix and was present in the fungal pellets while no antibiotics removal was 
observed; additionally, a decrease in Candida between days 42-56 resulted in a 
slight increase in antibiotics removal. Therefore, T. versicolor inhibition could be 
caused by the presence of Candida. 
The profile of psychiatric drugs concentration (excluding the carbamazepine 
family) in RA is very similar to the antibiotics profile in RA: a decrease in 
removal capacity is observed, well correlated with the invasion of the fungal 
pellets by Asterotremella. After the change in HWW, RA exhibited very low 
removal values, probably due to the hypotheses discussed above. Special 
attention can be paid to the antidepressant venlafaxine, a very recalcitrant 
compound typically detected in HWW and urban wastewaters (Evgenidou et al., 
2015). Venlafaxine is usually poorly removed, even in similar fungal reactors in 
sterile conditions (Badia-Fabregat et al., 2015). RA removed up to 95% of 
venlafaxine at Day 7. Interestingly, similar results can be found in the 
bibliography using the same fungal system in non-sterile conditions.  
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Other pharmaceutical compounds included antihypertensives, anthelmintics, 
anticoagulants, β-blockers, diuretics, tamsulosin, H1 and H2 antagonists, lipid 
regulators and dexamethasone. The main contributors of this miscellanea family 
are gemfibrozil and ranitidine, with extremely different concentrations in HWW1 
and HWW2. Gemfibrozil concentration was 6364 and 1921 ng·L-1 and ranitidine 
was 1830 and 20 ng·L-1 for HWW1 and HWW2 respectively. Both compounds 
could be removed well above 80% by RA and RB, except ranitidine in HWW2, 
where the initial concentration was very low. This combination of good 
degradability and lower initial concentrations between HWWs resulted in the 
decrease in overall removal of this miscellanea family observed in HWW2.  
Carbamazepine removal in the fungal reactor was well correlated with T. 
versicolor presence in the fungal pellets in HWW1 and averaged 60%, which 
was in accord with the bibliography (Zhang and Geißen, 2012). The decreased 
removal of CBZ and 10,11-epoxyCBZ in HWW2 could be due to the already 
discussed Candida presence. The increase in acridone concentration was 
attributed to the biotransformation of CBZ, 10,11-epoxyCBZ and acridine, this 
last one not analyzed in this study (Golan-Rozen et al., 2015). The ability to 
completely remove 2-hydroxyCBZ remained unaltered during the whole 
treatment. Cruz-Morató et al. (2013) also found an increase in acridone 
concentration when non-sterile wastewater was treated, but complete removal 
when treating a sterile matrix. Contrarily, 46% removal of 2-hydroxyCBZ was 
achieved in sterile conditions while in our study the complete removal was 
obtained in non-sterile matrices. Therefore, other microorganisms may play a 
role in acridone accumulation and 2-hydroxyCBZ removal in non-sterile fungal 
operations. Jelic et al. (2011) deduced that 10,11-epoxyCBZ could appear by 
23 
 
deconjugation of glucuronides. Glucoronidases are a type of transferase 
enzyme present in white-rot fungi and used in the catabolism of organic 
pollutants. Transferases catalyze the formation of glucoside, glucuronide, 
xyloside, sulphate or methyl conjugates from several compounds, increasing its 
solubility and reducing its toxicity (Harms et al., 2011). In fact, conjugation of 
xenobiotics has been widely reported (Hundt et al., 2000; Ichinose et al., 1999). 
The deconjugation of ketoprofen in the fungal reactor –but not in the 
uninoculated reactor has been suggested above. Therefore, it is proposed that 
Trametes versicolor could enhance the deconjugation of such compounds. 
In general, the global removals of both treatments RA and RB are similar due to 
ibuprofen and acetaminophen being the main contributors to the overall PhACs 
concentration and both being easily removed. Activated sludge in WWTP is also 
reported to remove several of these compounds. However, when highly 
recalcitrant xenobiotics are taken in account, like the compounds in antibiotic 
and psychiatric drugs families, the fungal treatment overpowered the 
uninoculated reactor. These families are not only very recalcitrant but also the 
main contributors to effluent overall toxicity and therefore environmental risk 
(Lucas et al., 2016). Fungal effluent exhibited lower concentrations of such 
products and lower toxicity values, as discussed below. 
In an attempt to evaluate the capacity of both reactors to degrade or transform 
other compounds not included in the chemical analysis an acute toxicity 
bioassay with the bacterium Vibrio fischeri was performed. In addition, the 
approach could be used to evaluate the risk involved with the disposal of a 
potentially fungal-treated and non-treated hospital effluent into the sewage 
system. The Environmental Protection Agency (2004) recommends 0.3 TU as a 
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threshold for  acute toxicity and 1.0 TU for chronic toxicity. The fungal treatment 
succeeded in maintaining the acute toxicity at 0.0 TU during the whole 
treatment. This indicated that T. versicolor removed non-analyzed toxic 
compounds and that no toxic metabolites were generated, or that potential toxic 
intermediates were also degraded, as pointed out by Cruz-Morató et al. (2013). 
The absence of toxicity suggested the possibility of disposal of the effluent to 
the sewage system. Contrarily, the uninoculated reactor raised the acute toxicity 
of the initial HWW to 27 TU, implying that the effluent should not be disposed of, 
that non-analyzed toxic compounds were not removed or that toxic metabolites 
were formed –and not degraded.      
5. Conclusions 
T. versicolor in pelleted morphology was maintained in a fungal reactor treating 
flocculated non-sterile real hospital wastewater for two months with an HRT of 3 
d. A partial biomass renovation strategy was used to maintain T. versicolor 
activity throughout the treatment, with a CRT of 21 d. A DGGE and sequencing 
approach confirmed that T. versicolor survived during the whole treatment. 
Regardless, longer operations might be needed to achieve a steady community 
structure.  
81 pharmaceutical compounds were analyzed and 46 were detected. Fungal 
treatment consistently removed most of the detected PhACs, including the most 
recalcitrant ones. Treated wastewater effluent did not exhibit any toxicity and 
therefore the operation might have removed potential toxic metabolites. Some 
interspecies interactions favored and some obstructed removal of some PhACs. 
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To the best of the authors’ knowledge this is the first time a fungal treatment 
was implemented for 2 months treating non-sterile HWW. 
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Fig.1. Evolution of laccase activity and glucose concentration during the 
continuous treatments with an HRT of 3 d. Black circles represent the reactor 
with T. versicolor and white circles, the uninoculated reactor. Vertical dotted 
lines represent weekly partial biomass renovation; the vertical dashed line, the 
change of wastewater. 
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Fig.2. Evolution of total suspended solids concentration during the treatments. 
Black circles represent the reactor with T. versicolor; white circles, the 
uninoculated reactor. Dotted lines represent weekly partial biomass renovation; 
the dashed line, the change of wastewater. 
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Fig.3. Pharmaceuticals concentration (in bars) and degradation (in circles) by 
families: analgesics and anti-inflammatories (top left), antibiotics (top right), 
psychiatric drugs not including carbamazepine and carbamazepine 
transformation products (bottom left) and the rest of PhACs (bottom right). Black 
bars/circles represent the reactor with T. versicolor and gray bars/circles, the 
uninoculated reactor; white patterned bars, the initial concentrations of each 
family. Dotted lines represent weekly partial biomass renovation; the dashed 
line, the change of wastewater. 
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Fig.4. Carbamazepine and carbamazepine transformation products 
concentration. Black bars represent the reactor with T. versicolor and gray bars, 
the uninoculated reactor; white patterned bars, the initial concentration of each 
product. Dotted lines represent weekly partial biomass renovation; the dashed 
line, the change of wastewater. 
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Fig.5.  Phylogenetic assignment of fungal sequences from the HWWs, the liquid 
matrix (RA) and pelleted biomass (PRA) of the inoculated reactor, and from the 
liquid matrix of the non-inoculated reactor (RB). Data is presented in form of 
relative abundance, previously calculated with a semi-quantitative DGGE matrix 
and sequenced bands from the DGGE gels. Narrow bands represent the initial 
fungal composition of the two wastewaters; broad bands, the fungal 
composition during the treatments. 
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Fig.6. Phylogenetic assignment of bacterial sequences from the HWWs, the 
liquid matrix (RA) and pelleted biomass (PRA) of the inoculated reactor, and 
from the liquid matrix of the non-inoculated reactor (RB). Data is presented in 
form of relative abundance, previously calculated with a semi-quantitative 
DGGE matrix and sequenced bands from the DGGE gels. Narrow bands 
represent the initial bacterial composition of the two wastewaters; broad bands, 
the bacterial composition during the treatments.  
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Table 1.Physicochemical characterization of the hospital wastewaters. 
Sampling date
Non flocculated Flocculated Non flocculated Flocculated
pH 7.8 8.1 8.7 8.0
Conductivity (mS·cm
-1
) 1.99 1.98 1.69 1.29
Absorbance at 650 nm 0.215 0.000 0.265 0.012
Chloride (mg Cl·L
-1
) 284.3 315.0 271.3 216.5
Sulfate (mg S·L
-1
) 67.1 73.1 59.9 43.6
Nitrate (mg N·L
-1
) 0.0 0.1 4.1 2.7
Phosphate (mg P·L
-1
) 1.3 2.0 0.5 0.2
Ammonia (mg N · L
-1
) 36.0 35.6 9.9 9.7
TSS (mg·L
-1
) 284 58 193 93
COD (mg O2·L
-1
) 633 215 1012 300
DIC (mg·L
-1
) 94 ± 1 71 ± 1 49 ± 1 39 ± 1
DOC (mg·L
-1
) 50 ± 4 53 ± 4 211 ± 11 56 ± 5
14/09/2015 26/10/2015
HWW1 HWW2
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Table 2. Pharmaceuticals initial concentration and removal percentage during the treatments. 
C (ng·L-1) C (ng·L-1)
Acetaminophen > 20000 > 99.3 ± 0 > 85.7 ± 28 > 20000 > 99.5 ± 1 100.0 ± 0
Diclofenac 951.3 99.8 ± 0 95.9 ± 8 bld - -
Ibuprofen >20000 > 85.5 ± 19 > 88.7 ± 6 3960.14 84.6 ± 2
b
93.0 ± 2
b
Ketoprofen 5109.3 -3.6 ± 84 71.5 ± 20 2432.33 -54.4 ± 72
b
79.8 ± 25
b
Phenazone bld - - 9.23 -314.0 ± 139 -147.3 ± 192
Total 46061.9 81.9 ± 15 85.6 ± 14 26404.07 82.9 ± 6
b
97.0 ± 2
b
Thiabendazole blq 70.0 ± 0 70.0 ± 0 9.10 97.7 ± 0
b
92.3 ± 0
b
Albendazole blq - -1338.7 ± 2724 blq - -
Total 0.9 53.3 ± 0 -266.8 ± 651 9.32 95.4 ± 0
b
90.1 ± 0
b
Azithromycin bld - - 45.36 -95.5 ± 107
b
88.5 ± 21
b
Ciprofloxacin 366.4 47.1 ± 25 -32.8 ± 67 266.90 -7.2 ± 16 -2.5 ± 29
Ronidazole bld -7745.2 ± 15490 -16726.3 ± 3627 bld -18135.5 ± 1690 -28321.6 ± 9351
Sulfamethoxazole 1130.4 78.2 ± 9
a
29.0 ± 31
a
55.85 34.8 ± 76 -42.6 ± 87
Trimethoprim 748.3 52.3 ± 35
a
-27.8 ± 54
a
81.80 -26.9 ± 96 -42.1 ± 67
Ofloxacin 2537.1 71.1 ± 14
a
3.8 ± 21
a
459.39 -57.8 ± 168 -65.4 ± 54
Total 4783.0 67.5 ± 17
a
1.0 ± 17
a
909.60 -42.3 ± 89 -45.0 ± 30
Warfarin 10.0 94.8 ± 0 94.8 ± 0 bld - -
Total 10.0 94.8 ± 0 94.8 ± 0 bld - -
Valsartan 112.7 34.2 ± 22 43.4 ± 46 55.46 -44.6 ± 63 15.6 ± 18
Total 112.7 34.2 ± 22 43.4 ± 46 55.46 -44.6 ± 63 15.6 ± 18
Atenolol 59.4 14.3 ± 37
a
78.7 ± 23
a
154.45 67.5 ± 24 60.9 ± 19
Propanolol bld - - bld blq blq
Sotalol 251.6 -151.9 ± 29 -205.2 ± 65 bld -10442.4 ± 20885 -17997.6 ± 35995
Total 327.5 -114.1 ± 27 -143.3 ± 54 171.16 32.9 ± 23 3.5 ± 41
Furosemide bld -664.4 ± 1431 -1018.9 ± 2124 161.88 97.6 ± 0 96.2 ± 3
Hydrochlorothiazide 408.4 58.4 ± 34 23.1 ± 14 650.78 10.9 ± 12 21.8 ± 2
Total 412.3 51.6 ± 45 13.2 ± 10 812.66 28.2 ± 10 36.6 ± 1
Tamsulosin bld - -58.3 ± 117 7.30 41.6 ± 5
b
98.7 ± 0
b
Total bld - -58.3 ± 117 7.30 41.6 ± 5
b
98.7 ± 0
b
Ranitidine 1830.3 96.7 ± 3 89.9 ± 6 20.43 -2.4 ± 107 -77.3 ± 61
Loratadine 1.2 46.9 ± 33 75.5 ± 0 bld -89.6 ± 113 -116.7 ± 135
Total 1831.5 96.7 ± 3 89.8 ± 6 20.71 -3.6 ± 105 -77.9 ± 62
Atorvastatin 14.9 94.9 ± 7 90.1 ± 15 13.77 95.6 ± 2 71.1 ± 28
Fluvastatin bld - -306.2 ± 612 bld - -
Gemfibrozil 6364.1 100.0 ± 0
a
83.6 ± 3
a
1921.34 85.1 ± 19 90.3 ± 19
Total 6381.8 99.9 ± 0
a
83.5 ± 3
a
1937.80 85.1 ± 19 90.1 ± 19
10.11-epoxyCBZ 673.2 43.6 ± 9 81.3 ± 30 1816.91 25.4 ± 6
b
82.6 ± 35
b
2-hydroxyCBZ 1661.1 99.9 ± 0 76.7 ± 46 > 2000 > 74.9 ± 50
b
> 18.3 ± 24
b
Acridone 126.0 -183.5 ± 43
a
74.5 ± 0
a
225.85 -295.8 ± 221
b
6.5 ± 62
b
Alprazolam bld - - 10.04 -17.7 ± 41 4.4 ± 41
Carbamazepine 251.4 61.0 ± 19
a
16.0 ± 8
a
270.09 22.7 ± 7 11.6 ± 7
Citalopram 297.4 39.0 ± 18
a
-18.2 ± 5
a
351.00 -4.4 ± 38 -22.0 ± 14
Diazepam bld -58.3 ± 117 - bld -58.3 ± 117 1.9 ± 4
Fluoxetine bld - - bld - -
Norfluoxetine 12.5 90.1 ± 0 -26.5 ± 233 bld - -
Olanzapine 131.5 98.7 ± 2 -44.6 ± 153 66.98 99.2 ± 0
b
-73.9 ± 104
b
Setraline 98.8 98.3 ± 0 98.3 ± 0 127.85 98.7 ± 0 55.1 ± 50
Razodone 36.3 98.0 ± 0
a
-112.5 ± 94
a
20.86 69.7 ± 54 29.7 ± 54
Venlafaxine 495.3 41.0 ± 41
a
-18.2 ± 7
a
146.18 -19.2 ± 79 -78.8 ± 46
Total 3791.9 54.8 ± 24 47.6 ± 22 5044.96 30.0 ± 24 34.7 ± 18
Dexamethasone 121.8 77.2 ± 44 33.5 ± 76 bld -34501.3 ± 23481 -32983.9 ± 23315
Total 121.8 77.2 ± 44 33.5 ± 76 bld -34501.3 ± 23481 -32983.9 ± 23315
Anticoagulants
Therapeutical group Compound HWW1 HWW2
RA RB RA RB
Removal (%) Removal (%) Removal (%) Removal (%)
Analgesics and 
anti-inflammatories
Anthelmintics
Antibiotics
Histamine H1 and H2
receptor antagonists
Lipid regulators
Psychiatric drugs
Synthetic
glucocorticoid
Antihypertensives
b-blockers
Diuretics
Drug against 
prostatic hyperplasia
Bql: below limit of quantification; bld: below limit of detection. 
a,b
 Statistically different (p < 0.05). 
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Table 3. Chemical oxygen demand of effluent of reactors during the treatment. 
RA RB
0 215 215
7 358 1900
21 3141 1115
42 379 1260
56 292 1335
COD (mg·L-1)
Time (d)
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Fig. S1. DGGE profiles of fungal and bacterial communities detected in the inoculated reactor (RA), pellet 
fraction of the inoculated reactor (PRA) and non-inoculated reactor (RB) using the primer sets EF4-
ITS4/ITS1-ITS2 and 341f-907r respectively. Representative bands (▲) are labeled according to their 
source. (F) Fungi, (B) Bacteria. 
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Table S1. Phylogenetic affiliations of bacterial 16S rRNA gene and fungal ITS 
sequences obtained from the reactors after DGGE. 
DGGE 
band 
Closest cultured BLAST match 
Accession 
number 
Similarity 
(%) 
Phylogenetic 
affiliation (Phylum) 
F01-02 Candida sojae KJ722419 100 Ascomycota 
F03-06 Phialemoniopsis curvata AB278180 98 Ascomycota 
F07, F9 Asterotremella humicola KC118118 100 Basidiomycota 
F08, F10 Trametes versicolor KR261581 100 Basidiomycota 
F11-13 Isaria cf. farinosa FN548150 99 Ascomycota 
F14 Tremella exigua KP986514 100 Basidiomycota 
F15 Trichoderma asperellum KR856224 100 Ascomycota 
F16-18 Trichoderma asperellum KR856224 100 Ascomycota 
B01 Flavobacterium oncorhynchi KT354259 100 Bacteroidetes 
B02 Flavobacterium sp. JF915323 99 Bacteroidetes 
B03-04 Elizabethkingia miricola LN995715 100 Bacteroidetes 
B05 
Chryseobacterium 
meningosepticum 
AF207076 100 Bacteroidetes 
B06 Bacteroides oleiciplenus NR_113070 95 Bacteroidetes 
B07 Faecalibacterium prausnitzii HQ457025 100 Firmicutes 
B08 Dyadobacter fermentans LN890052 100 Bacteroidetes 
B09 Dyadobacter sp. DQ207362 100 Bacteroidetes 
B10 Microvirgula aerodenitrificans LN997979 100 Proteobacteria (β) 
B11 Lactococcus lactis KU942499 100 Firmicutes 
B12 Burkholderia gladioli KT862889 100 Proteobacteria (β) 
B13 Pandoraea sputorum LN995687 100 Proteobacteria (β) 
B14 Cyanobacterium TDX16 KJ599678 95 Cyanobacteria 
B15 Acetobacter aceti KR261398 99 Proteobacteria (α) 
B16 Rhizobium sp. KT387839 100 Proteobacteria (α) 
B17 Comamonas aquatica LN558648 99 Proteobacteria (β) 
B18 Comamonas aquatica KT716080 99 Proteobacteria (β) 
B19 Paenibacillus sp. JX469414 99 Firmicutes 
B20 Stenotrophomonas sp. KR922087 100 Proteobacteria (γ) 
B21 Magnetospirillum sp. KM289194 99 Proteobacteria (α) 
B22 Microbacteriaceae bacterium KR082269 100 Actinobacteria 
Abbreviation: BLAST, Basic Local Alignment Search Tool. 
